Oxlumo 94.5 mg (Lumasiran (Lumasiran Sodium) SOLUTION) 94.5 MG

OXLUMO 94.5 MG is a subcutaneous solution containing lumasiran sodium, used for managing certain metabolic conditions. This medication is designed to help regulate specific enzyme activities in the body.

Strength

94.5 MG

Manufacturer / TM Owner

ALNYLAM NETHERLANDS B.V.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OXLUMO 94.5 MG is primarily used for the treatment of primary hyperoxaluria type 1 (PH1), a rare genetic disorder. This condition causes the body to produce too much oxalate, which can lead to kidney stones and other complications. OXLUMO works by reducing the production of oxalate, helping to manage symptoms and prevent further damage. Patients often wonder, 'what is OXLUMO used for?' and the answer lies in its ability to address the underlying cause of PH1.

Side Effects

Common effects of OXLUMO 94.5 MG may include injection site reactions, such as redness, swelling, or pain. Some users might also experience fatigue, nausea, or abdominal pain. These effects are generally mild and temporary, but it's important to monitor any persistent or severe symptoms.

Precautions & Warnings

OXLUMO 94.5 MG should be administered under the supervision of a healthcare provider. It is important to follow the prescribed dosage and administration instructions carefully. Patients with a history of severe allergic reactions to lumasiran sodium or any of the ingredients should avoid using this medication. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

OXLUMO 94.5 MG may interact with other medications, particularly those that affect liver enzymes. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of OXLUMO, so it's best to consult with a healthcare professional before making any changes.

Frequently Asked Questions

OXLUMO 94.5 MG is used to treat primary hyperoxaluria type 1 (PH1), a genetic disorder that causes the body to produce too much oxalate.

OXLUMO 94.5 MG is administered via subcutaneous injection, typically under the supervision of a healthcare provider.

Common side effects may include injection site reactions, fatigue, nausea, and abdominal pain.

It is important to discuss all current medications with your healthcare provider to avoid potential interactions.

Patients with a history of severe allergic reactions to lumasiran sodium or any of the ingredients should avoid using this medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.